In this file
A branded-drug consultation price is different from a bundled compounded-medication program. That detail matters when comparing the proposed prescription, payment schedule, and access to help.
This provider file follows the company’s published material and the questions it leaves open. It covers the care arrangement, price, cancellation boundaries, and contact routes; it does not certify the business or determine whether a treatment is appropriate for a particular person.
Understand the care arrangement
BeyondMD organizes its catalog into several treatment programs and separates branded-drug consultation offerings from compounded preparations. The distinction is especially important when a small consultation figure appears beside a program price that may include medication. Ask what the clinician will evaluate and what the purchase actually provides.
Name the organizations involved in your own plan. The website operator, clinical practice, and pharmacy may be separate businesses. A patient should know which one is responsible for a medical decision, which holds the account, and which handles the medication.
Read the price in its proper context
The weight-management page lists branded Zepbound and Wegovy consultation programs starting at $129. It also shows compounded semaglutide with B12 from $125 and compounded tirzepatide injections from $199. These labels do not establish identical inclusions or time periods. Confirm medication charges and supply duration for the selected pathway.
Record the total paid today, the period it buys, and the next payment. If a figure is expressed per month but collected for several months, keep both numbers in the comparison. Our price-comparison worksheet helps separate a low initial figure from the continuing commitment.
Find the cancellation boundary
A refund and cancellation policy is published, but the amount at risk depends on the specific program and the stage of clinical and pharmacy work. Request the relevant conditions before ordering, especially when choosing a consultation that may result in a prescription purchased separately.
A useful request names the next renewal and the current order separately. Ask for confirmation of both the effective cancellation date and the pharmacy status. Instructions for stopping or changing the medicine itself need to come from the treating professional.
Identify the actual prescription
The catalog includes injections, oral preparations, and branded consultation pathways. These cannot be compared solely by ingredient name. Ask the prescriber to identify the exact finished product, its route, and the reason for choosing it; an oral compounded program is not the same product as an approved branded tablet.
FDA approval concerns a particular drug product. A compounded preparation has not received that approval, and evidence for a different formulation cannot guarantee an individual result. Read the product-approval explanation and ask questions about the exact medicine proposed.
Contact and account help
BeyondMD’s published contact number is (888) 516-0285. The documented email route is customerservice@beyondmd.com.
Customer-service channel for the platform; identify the clinician or pharmacy for clinical questions.
Start from the official BeyondMD website to find its verified patient-account navigation. We have not signed into a private portal or measured its support response. Do not share passwords, access codes, payment-card details, or medical records with a review site.
Bring one concrete question to the consultation
Am I paying for a consultation only or for a medication program, and which additional pharmacy charges and follow-up visits should I budget for?
Write the answer beside the proposed prescription and agreement. If it describes a different product, an expired promotion, or a plan you are not eligible for, ask for clarification. Our pre-purchase checklist can help keep those questions organized.
Source notes
Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.
- TERMS OF SERVICE - beyondMD ↗Provider-published information · Checked September 22, 2026
- Weight Management & Metabolism Programs - beyondMD ↗Provider-published information · Checked September 22, 2026
- Home - BeyondMD - beyondMD ↗Provider-published information · Checked September 22, 2026
- FDA: concerns with unapproved GLP-1 drugs ↗Regulatory / public agency · Checked September 22, 2026
- FDA: risks of compounded drugs ↗Regulatory / public agency · Checked September 22, 2026